Author

Stéphanie Simon

Commissariat à l'Énergie Atomique et aux Énergies AlternativesORCID 0000-0002-6071-8255Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

Anne WijkhuiseniD· 2 shared Anne-Sophie GallouëtiD· 1 shared Asier Sáez‐CirióniD· 1 shared Benoı̂t FavieriD· 1 shared Catherine MenieriD· 1 shared Fanny RousseauiD· 1 shared Florian MeurisseiD· 1 shared Francis RelouzatiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Anne WijkhuisenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dual blockade of LILRB1 and LILRB2 enhances antiviral immune responses in SIV infection

Florian Meurisse, Sixtine Coindre, Anne Wijkhuisen, Romain Marlin, Laure Fournier Le Ray, Juliette Pons, Melyssa Yaugel-Novoa, Véronique Avettand-Fènoël, Laurent Abi‐Rached, Anne-Sophie Gallouët, Francis Relouzat, Maël Gourvès, Asier Sáez‐Cirión, Hisashi Arase, Gérard Zurawski, , Benoı̂t Favier

This study shows that blocking LILRB1 and LILRB2 with a dual-specific antibody enhances antiviral immune responses in SIV infection without adverse effects.

Advanced Science · Jul 30, 2026Peer-reviewedImmunology

Targeted fusion of Antibody-Secreting Cells: unlocking monoclonal antibody production with hybridoma technology

Fanny Rousseau, Catherine Menier, Patricia Brochard, Stéphanie Simon, Karla Perez‐Toralla, Anne Wijkhuisen

This study improves monoclonal antibody production by targeting specific antibody-secreting cells, achieving a 100% fusion yield and over 60% mAb secretion.

mAbs · May 26, 2025Peer-reviewedImmunology